Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomal biogenesis refers to the complex, regulated process by which lysosomes—membrane-bound organelles responsible for cellular degradation and recycling—are formed, maintained, and functionally integrated within cells. This process encompasses the synthesis of lysosomal proteins, their targeting to the lysosome, functional residence within the organelle, and eventual turnover. Key regulators include TFEB/TFE3 transcription factors. Defects in this pathway lead to various diseases, including lysosomal storage disorders and neurodegeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal Biogenesis.